$PFE Q3 '25 Earnings Results & Recap
Pfizer reported Q3 2025 revenues of $16.7 billion versus an estimate of $16.5B, with an adjusted EPS of $0.87, exceeding estimates of $0.63; the company is raising its full-year adjusted diluted EPS guidance to $3.00-$3.15.